Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Tamoxifen Use Tied to Diabetes Risk in Breast Cancer Survivors
But aromatase inhibitor use has no association with diabetes in older breast cancer survivors
This article is older than one year and is no longer available.

Copyright © 2011 HealthDay. All rights reserved.

April 21, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

AACR: Immune Checkpoint Inhibitors Promising in Melanoma

AACR: Changes Expected in Breast Cancer Rates

Guidance Offered for Managing Conflict With Patients

AACR: Longer Nighttime Fasting May Reduce Breast Cancer Risk

Suboptimal Prescribing Attitudes Could Signal Personal Distress

Apple HealthKit App Facilitates Doctor-Patient Communication